Collegium Pharmaceutical Inc (NAS:COLL)
$ 31.76 -0.19 (-0.59%) Market Cap: 1.04 Bil Enterprise Value: 1.35 Bil PE Ratio: 13.18 PB Ratio: 4.68 GF Score: 71/100

Q4 2021 Collegium Pharmaceutical Inc Earnings Call Transcript

Feb 24, 2022 / 09:30PM GMT
Release Date Price: $21.4 (-4.89%)
Operator

Greetings, and welcome to the Collegium Pharmaceuticals' Fourth Quarter and Full Year 2021 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the call over to Alex Dasalla, Head of Investor Relations and Corporate Communications.

Alex Dasalla
Collegium Pharmaceutical, Inc. - Head of IR

Thank you, operator. Welcome to Collegium Pharmaceuticals' fourth quarter 2021 earnings conference call. This is Alex Dasalla, Head of Investor Relations and Corporate Communications at Collegium Pharmaceutical. I'm joined today by Joe Ciaffoni, our Chief Executive Officer; Colleen Tupper, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer. Joe and Colleen will share some prepared remarks, and then we will take your questions.

Before we begin today's call, we want to remind participants that none of the information presented today is intended to be promotional, and that any forward-looking statements made today are made pursuant to the safe harbor provision of the Private

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot